Klinische Forschergruppe 228 - Immunopathogenesis and Therapy of Glomerulonephritis
This Clinical Research Group will bring together scientists with a strong expertise in human and experimental glomerulonephritis (U. Panzer, F. Thaiss, O.M. Steinmetz, C. Meyer-Schwesinger and R. Stahl), in cellular immunology (H-W. Mittrücker, C. Kurts and G. Tiegs) and in renal pathology (H. Hopfer, T. Wiech and U. Helmchen). Using state-of-the-art techniques including renal in vivo imaging and (transgenic) animal models, combined with prospective studies in a large cohort of patients with glomerulonephritis, this Clinical Research Unit seeks to better understand the immunopathogenesis of human and experimental glomerulonephritis. These experimental approaches will help to identify, characterize and validate new diagnostic, prognostic and therapeutic targets in human glomerulonephritis.